Trifunctional Antibody Catumaxomab Triggers Vaccination Effect Against Cancer
08-Jun-2011 -
TRION Pharma GmbH announced that the results from two different studies demonstrate catumaxomab’s capacity to activate the immune system in a way that can otherwise only be achieved through vaccination. The data were obtained by two independent research teams using catumaxomab in malignant ...
catumaxomab
gastric cancer
malignant ascites